Newsfeeds - Spark Newswire

1 minute read

Jefferies Initiates Coverage On Lexicon Pharmaceuticals with Hold Rating, Announces Price Target of $3

Today, 7:17 AM

Jefferies analyst Andrew Tsai initiates coverage on Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Hold rating and announces Price Target of $3.

LXRX

4 minute read

Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 7:17 AM

Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

ADMP

2 minute read

Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday

By Lisa Levin

Today, 7:17 AM

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.

8 minute read

Earnings

Earnings Scheduled For March 2, 2023

By Benzinga Insights

Today, 7:17 AM

Companies Reporting Before The Bell • argenx (NASDAQ:ARGX) is expected to report quarterly loss at $3.03 per share on revenue of $176.89 million.

ABEV

1 minute read

Lexicon Pharma’s Pain Candidate Fails In Postherpetic Neuralgia Study

By Vandana Singh

Today, 7:17 AM

Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) announced the topline results of RELIEF-PHN-1 Phase 2 proof-of-concept study of LX9211 in postherpetic neuralgia, a lasting pain in the areas of the skin that had shingles.

LXRX

1 minute read

Micron, Lexicon Pharmaceuticals And Some Other Big Stocks Moving Lower In Today’s Pre-Market Session

By Lisa Levin

Today, 7:17 AM

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. Westrock Coffee Company, LLC (NASDAQ: WEST) shares tumbled 10.9% to $11.90 in pre-market trading after gaining 10% on Wednesday.

IAG

3 minute read

Why ORIC Pharmaceuticals Shares Are Trading Higher By Around 46%; Here Are 27 Stocks Moving Premarket

By Lisa Levin

Today, 7:17 AM

Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares rose 77.7% to $0.0906 in pre-market trading. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.

ARTL

1 minute read

Lexicon’s Experimental Drug Shows Significant, Consistent Benefits In Diabetic Neuropathy Study

By Vandana Singh

Today, 7:17 AM

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) announced that full results from the RELIEF-DPN-1 trial of its investigational drug LX9211 were presented at the…

LXRX

1 minute read

Lexicon’s LX9211 Shows Significant And Consistent Benefits In The Treatment Of Painful Diabetic Neuropathy In Full Results From The Phase 2 RELIEF-DPN-1 Trial Presented At The 16th Annual Pain Therapeutics Summit

By Benzinga Newsdesk

Today, 7:17 AM

Achieved primary endpoint for reduction in average daily pain score (ADPS) at week 6 Significant benefits demonstrated on burning pain and on pain interference with sleep No evidence of withdrawal symptoms or

LXRX

1 minute read

Lexicon Pharmaceuticals Q2 EPS $(0.16), Inline, Sales $35.00K Miss $50.00K Estimate

By Bill Haddad

Today, 7:17 AM

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.16) per share which met the analyst consensus estimate. This is a 23.08 percent decrease over losses of $(0.13) per share from the same period last

LXRX